Our Compliance and Ethics Program (“Program”) is designed to support our mission to develop and commercialize safe, effective, and transformative treatment options for patients with debilitating diseases. We expect every member of the Kiniksa team to share this focus and understand that our success is not only about the results we get—it is about the way we achieve them—with integrity in every action and an unwavering commitment to patients.
The Program is built upon guidance issued by the Office of Inspector General of the Department of Health and Human Services and the codes of conduct issued by industry trade associations. It has oversight and input from the highest levels of management, including our Board of Directors, Chief Compliance Officer, and Corporate Compliance Committee. It is a shared undertaking to ensure every member of the Kiniksa team takes ownership of the Program to perform all of our activities ethically and reflect the highest standards as outlined in our Code of Business Conduct and Ethics.